# Pyxis Oncology (PYXS) — News

PYXS · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/pyxs/news

## Recent headlines

- [Pyxis Oncology announces closing of up to $282.6 million public offering](https://www.ainvest.com/news/pyxis-oncology-announces-closing-282-6-million-public-offering-2610) — AInvest Wire, Oct 2, 2026
  Pyxis Oncology, Inc. (Nasdaq: PYXS) has announced the closing of its public offering, which raised up to $282.6 million in gross proceeds. The offering included 36,047,919 shares of common stock and 1,883,121 pre-funded warrants, along with accompanying common warrants to purchase 49,310,352 shares…
- [Pyxis Oncology prices offering at combined $2.90/shr, warrant](https://www.ainvest.com/news/pyxis-oncology-prices-offering-combined-2-90-shr-warrant-2609) — AInvest Wire, Sep 30, 2026
- [Pyxis Oncology announces pricing of up to $282.6 million public offering](https://www.ainvest.com/news/pyxis-oncology-announces-pricing-282-6-million-public-offering-2609) — AInvest Wire, Sep 30, 2026
- [Pyxis Oncology announces proposed public offering](https://www.ainvest.com/news/pyxis-oncology-announces-proposed-public-offering-2609) — AInvest Wire, Sep 29, 2026
  Pyxis Oncology, Inc. (NASDAQ: PYXS) has announced a private placement of equity securities, which may serve as a precursor to a broader public offering. On June 30, 2026, the company entered into a securities purchase agreement with institutional and accredited investors, under which it agreed to…
- [Pyxis Oncology: Terminates $150.00M ATM offering, no shares sold to date - SEC filing](https://www.ainvest.com/news/pyxis-oncology-terminates-150-00m-atm-offering-shares-sold-date-sec-filing-2609) — AInvest Wire, Sep 29, 2026
  Pyxis Oncology, Inc. (NASDAQ: PYXS) has terminated its $150 million at-the-market (ATM) stock offering program, according to an SEC filing. The company had initially established the ATM program as a flexible capital-raising mechanism but has now opted to discontinue it, with no shares having been…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).
